NSE - Delayed Quote INR
Aurobindo Pharma Limited (AUROPHARMA.NS)
At close: 3:30 PM GMT+5:30
Research Analysis
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2022) | Next Year (2023) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 25 | 25 |
Avg. Estimate | 14 | 14.17 | 55.77 | 62.29 |
Low Estimate | 13.3 | 13.94 | 47.7 | 49.1 |
High Estimate | 14.7 | 14.4 | 63.52 | 69.28 |
Year Ago EPS | -- | -- | -- | 55.77 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2022) | Next Year (2023) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 26 | 25 |
Avg. Estimate | 61.7B | 63.62B | 250.11B | 271.28B |
Low Estimate | 59.2B | 62.27B | 234.74B | 242.8B |
High Estimate | 64.52B | 65.38B | 268.4B | 298.66B |
Year Ago Sales | -- | -- | -- | 250.11B |
Sales Growth (year/est) | -- | -- | -- | 8.50% |
Earnings History
CURRENCY IN USD | 6/30/2021 | |
---|---|---|
EPS Est. | -- | 14.53 |
EPS Actual | -- | 13.14 |
Difference | -- | -1.39 |
Surprise % | -- | -9.60% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2022) | Next Year (2023) |
---|---|---|---|---|
Current Estimate | 14 | 14.17 | 55.77 | 62.29 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2022) | Next Year (2023) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 1 | -- |
Up Last 30 Days | -- | -- | 1 | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
CURRENCY IN USD | AUROPHARMA.NS | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 3.10% |
Next Qtr. | -- | -- | -- | 8.00% |
Current Year | -- | -- | -- | 2.30% |
Next Year | 11.70% | -- | -- | 13.20% |
Next 5 Years (per annum) | 11.30% | -- | -- | 11.85% |
Past 5 Years (per annum) | 8.19% | -- | -- | -- |
Related Tickers
ALKEM.NS Alkem Laboratories Limited
6,110.25
-0.78%
TORNTPHARM.NS Torrent Pharmaceuticals Limited
3,339.65
-1.56%
ZYDUSLIFE.NS Zydus Lifesciences Limited
988.20
-1.74%
SUNPHARMA.NS Sun Pharmaceutical Industries Limited
1,887.55
-0.50%
GLENMARK.NS Glenmark Pharmaceuticals Limited
1,682.25
-2.01%
DIVISLAB.NS Divi's Laboratories Limited
5,817.95
-1.81%
GLAND.NS Gland Pharma Limited
1,647.60
-1.65%
JBCHEPHARM.NS J. B. Chemicals & Pharmaceuticals Limited
1,900.45
-0.29%
AJANTPHARM.NS Ajanta Pharma Limited
2,977.40
-5.19%
GRANULES.NS Granules India Limited
555.70
-5.94%